New Zealand Food Stock News

With a median price-to-earnings (or "P/E") ratio of close to 18x in New Zealand, you could be forgiven for feeling...

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But in contrast you can...

Genesis Energy has reached Final Investment Decision for the 136 MWp Edgecumbe Solar Farm in New Zealand’s Bay of Plenty, targeting first generation in the second half of FY27 under its Gen35 renewable strategy. The on-balance-sheet funding of Edgecumbe, with potential capital recycling post-commissioning, highlights Genesis’s flexible approach to financing growth while aiming to preserve its BBB+ credit rating. Next, we’ll examine how committing to the 136 MWp Edgecumbe Solar Farm could...

Fisher & Paykel Healthcare has already reported half-year 2025 results showing sales of NZ$1,088.5 million and net income of NZ$213.0 million, alongside higher basic earnings per share and an increased interim dividend. The company also raised its full-year revenue and net profit guidance, signaling management confidence that recent operational momentum can continue. Next, we’ll explore how the upgraded full-year earnings guidance may influence Fisher & Paykel Healthcare’s existing...

Green Cross Health Limited ( NZSE:GXH ) will increase its dividend on the 18th of December to NZ$0.0353, which is 20...

In recent weeks, the Asian markets have shown resilience, with small-cap stocks gaining attention amid shifting economic dynamics and investor sentiment. As these smaller companies navigate a landscape marked by evolving trade policies and technological advancements, identifying promising opportunities becomes crucial for investors looking to capitalize on potential growth. In this context, understanding key market trends and company fundamentals is essential for evaluating stocks that may...

Tower Limited ( NZSE:TWR ) came out with its full-year results last week, and we wanted to see how the business is...

Key Insights Significant control over Chorus by individual investors implies that the general public has more power to...

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

It looks like Green Cross Health Limited ( NZSE:GXH ) is about to go ex-dividend in the next 3 days. The ex-dividend...

a2 Milk (NZSE:ATM) has secured approvals from New Zealand and Chinese authorities for its plan to transition China label infant formula registrations to a2MC branding. The company expects to make the final regulatory submission next month, which will support future product launches. See our latest analysis for a2 Milk. Momentum has been building for a2 Milk, with the latest regulatory wins in China and upbeat earnings guidance helping to extend a rally that has seen a 73.34% year-to-date...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Radius Residential Care Limited ( NZSE:RAD ) is about to trade ex-dividend in the next four days. The ex-dividend date...

The recent earnings posted by Oceania Healthcare Limited ( NZSE:OCA ) were solid, but the stock didn't move as much as...

Last week saw the newest half-year earnings release from Fisher & Paykel Healthcare Corporation Limited ( NZSE:FPH...

Rakon (NZSE:RAK) just posted its H1 2026 results, reporting revenue of 62.004 million NZD and basic EPS of 0.0196 NZD. Looking back, the company has seen revenue go from 41.657 million NZD in H1 2025 to 66.756 million NZD in H2 2024 before reaching the latest figure. EPS moved from -0.046 NZD up to 0.018276 NZD, then to the current 0.0196 NZD. With these numbers out, it is clear margin performance continues to shape investor discussions around the business. See our full analysis for...

ikeGPS Group (NZSE:IKE) has just released its H1 2026 results, reporting revenue of $12.98 million and a basic EPS of -$0.064. Looking at the recent trend, the company has seen revenue move from $10.59 million in H2 2024 to $12.17 million in H1 2025, before reaching $12.98 million in the latest period. EPS remained negative over the same intervals. Overall, the numbers show that while top-line growth persists, earnings and margins continue to face headwinds. See our full analysis for ikeGPS...

Gentrack Group (NZSE:GTK) has just reported a strong set of full-year earnings, highlighting a jump in both revenue and net income for 2025. This was accompanied by positive updates on its international platform strategy. See our latest analysis for Gentrack Group. Following the earnings announcement and new client wins for its g2 platform, Gentrack Group’s share price has leapt 39% in the past week, reflecting renewed optimism after a period of tepid returns. Its one-year total shareholder...

One thing we could say about the analysts on Pacific Edge Limited ( NZSE:PEB ) - they aren't optimistic, having just...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Ryman Healthcare (NZSE:RYM) has just reported H1 2026 financial results, posting total revenue of $806.7 million NZD and basic EPS of -0.64 NZD for the trailing twelve months. Historically, the company has seen revenue climb from $355.2 million NZD in H2 2024 to $394.0 million NZD by H2 2025. Basic EPS over recent halves ranged from -0.72 NZD to 0.14 NZD. Margins continue to face pressure as profitability remains elusive, making this an essential set of numbers for investors to digest. See...

Tower (NZSE:TWR) has just reported its FY 2025 first half results, booking $306.9 million in revenue and basic EPS of $0.15 NZD. The company has seen revenue rise over recent periods, moving from $234.3 million in the first half of FY 2023 to $278.5 million in FY 2024, before reaching this half's $306.9 million result. Margins have expanded as net profit climbed, keeping investors focused on the earnings trends heading into the rest of the year. See our full analysis for Tower. Let’s put the...

Stride Property Group (NZSE:SPG) has just reported H1 2026 results, with revenue coming in at NZ$136.2 million and basic EPS at NZ$0.081952 for the trailing twelve months. Historically, the company saw revenue rise from NZ$53.4 million in H2 2024 to NZ$76.1 million in H2 2025. EPS moved from -NZ$0.010129 to NZ$0.005711 over that span. Margins held steady, giving investors a clear snapshot into the REIT's operational results. See our full analysis for Stride Property Group. Now it’s time to...

Fisher & Paykel Healthcare (NZSE:FPH) just posted its H1 2026 results with revenue of NZ$1.1 billion and net income of NZ$213 million, as well as basic EPS of NZ$0.36. Over the last year, the company has seen total revenue rise from NZ$951.2 million in H1 2025 to the latest NZ$1.1 billion. Net income has climbed from NZ$153.2 million to NZ$213 million. Margins have notably expanded this period, signalling a clear improvement in profitability for investors to consider. See our full analysis...